Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maarten Boers

Showing results (101-110 of 395) with videos related to

Pageof 40
Sort By:
Arthritis and Rheumatism|August 1, 2007
Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritisFrederick Wolfe, Johannes J Rasker, Maarten Boers, et al.
Brazilian Journal of Physical Therapy|May 3, 2017
Core outcome sets for research and clinical practiceAlessandro Chiarotto, Raymond W Ostelo, Dennis C Turk, et al.
Plos One|February 6, 2014
Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort studyAlper M van Sijl, Maarten Boers, Alexandre E Voskuyl, et al.
Annals of the Rheumatic Diseases|June 14, 2022
Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 yearsIngrid M Visman, Maarten Boers, Daisy Vedder, et al.
Current Opinion in Rheumatology|March 3, 2022
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidenceMariana Luís, Maarten Boers, Ken Saag, et al.
The Journal of Rheumatology|July 5, 2011
OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical TrialsPeter Brooks, Maarten Boers, Lee S Simon, et al.
Arthritis and Rheumatism|May 30, 2006
The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by HarrisJohannes W G Jacobs, Maarten Boers, John R Kirwan, et al.
Arthritis and Rheumatism|June 10, 2004
Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidityMaarten Boers, Ben Dijkmans, Sherine Gabriel, et al.
Journal of Clinical Epidemiology|May 25, 2018
Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain: A systematic reviewAlessandro Chiarotto, Caroline B Terwee, Steven J Kamper, et al.
The Journal of Rheumatology|September 10, 2009
The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challengesAnnelies Boonen, Gerold Stucki, Walter Maksymowych, et al.
Pageof 40

Showing results (101-110 of 395) with videos related to

Sort By:
Pageof 40
Arthritis and Rheumatism|August 1, 2007
Minimal disease activity, remission, and the long-term outcomes of rheumatoid arthritisFrederick Wolfe, Johannes J Rasker, Maarten Boers, et al.
Brazilian Journal of Physical Therapy|May 3, 2017
Core outcome sets for research and clinical practiceAlessandro Chiarotto, Raymond W Ostelo, Dennis C Turk, et al.
Plos One|February 6, 2014
Confounding by indication probably distorts the relationship between steroid use and cardiovascular disease in rheumatoid arthritis: results from a prospective cohort studyAlper M van Sijl, Maarten Boers, Alexandre E Voskuyl, et al.
Annals of the Rheumatic Diseases|June 14, 2022
Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 yearsIngrid M Visman, Maarten Boers, Daisy Vedder, et al.
Current Opinion in Rheumatology|March 3, 2022
The safety of glucocorticoids in the treatment of inflammatory rheumatic disease: new evidenceMariana Luís, Maarten Boers, Ken Saag, et al.
The Journal of Rheumatology|July 5, 2011
OMERACT 10--International Consensus Conference on Outcome Measures in Rheumatology Clinical TrialsPeter Brooks, Maarten Boers, Lee S Simon, et al.
Arthritis and Rheumatism|May 30, 2006
The benefit of low-dose glucocorticoid treatment in early rheumatoid arthritis may outweigh the risk: comment on the editorial by HarrisJohannes W G Jacobs, Maarten Boers, John R Kirwan, et al.
Arthritis and Rheumatism|June 10, 2004
Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidityMaarten Boers, Ben Dijkmans, Sherine Gabriel, et al.
Journal of Clinical Epidemiology|May 25, 2018
Evidence on the measurement properties of health-related quality of life instruments is largely missing in patients with low back pain: A systematic reviewAlessandro Chiarotto, Caroline B Terwee, Steven J Kamper, et al.
The Journal of Rheumatology|September 10, 2009
The OMERACT-ICF Reference Group: integrating the ICF into the OMERACT process: opportunities and challengesAnnelies Boonen, Gerold Stucki, Walter Maksymowych, et al.
Pageof 40